⌘K

Login Start Free

Home/Filings/4/0001142576-12-000013

4//SEC Filing

Hartman Kurt M 4

Accession 0001142576-12-000013

CIK 0001142576other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 8:19 PM ET

Size

5.4 KB

Accession

0001142576-12-000013

Insider Transaction Report

Form 4

Period: 2012-02-07

OPTIMER PHARMACEUTICALS INCOPTR

General Counsel and Access

Transactions

Award
Stock Option (right to buy)
2012-02-07+18,750→ 18,750 total
Exercise: $13.51Exp: 2022-02-07→ Common Stock (18,750 underlying)

Footnotes (1)

[F1]1/4 of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/48 of the shares shall vest each month thereafter, subject to optionee continuing to be a service provider on each such date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

OPTIMER PHARMACEUTICALS INC

CIK 0001142576

Entity typeother

Related Parties

1

filerCIK 0001506523

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 8:19 PM ET
Size: 5.4 KB

View on SEC.gov